Literature DB >> 25006724

Hormone therapy in premenopausal women with early-stage breast cancer.

Hope S Rugo1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25006724     DOI: 10.1056/NEJMe1405746

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Targeted delivery of paclitaxel by functionalized selenium nanoparticles for anticancer therapy through ROS-mediated signaling pathways.

Authors:  Guifang Gong; Bailing Fu; Caixin Ying; Zhiqin Zhu; Xiaoqian He; Yingying Li; Zhuanxing Shen; Qingshan Xuan; Yanqing Huang; Yan Lin; Yinghua Li
Journal:  RSC Adv       Date:  2018-11-30       Impact factor: 4.036

Review 2.  Clinical utilities of aromatase inhibitors in breast cancer.

Authors:  Saranya Chumsri
Journal:  Int J Womens Health       Date:  2015-05-06

3.  Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.

Authors:  Changqie Pan; Yuqing Liu; Minyu Zhou; Wensheng Wang; Min Shi; Malcolm Xing; Wangjun Liao
Journal:  Int J Nanomedicine       Date:  2018-02-27

4.  Heme Oxygenase-1 Inhibits Tumor Metastasis Mediated by Notch1 Pathway in Murine Mammary Carcinoma.

Authors:  Qiang Li; Qi Liu; Wanpeng Cheng; Huiyan Wei; Wenqian Jiang; Fang E; Yuan Yu; Jianfeng Jin; Chaoxia Zou
Journal:  Oncol Res       Date:  2019-02-14       Impact factor: 5.574

5.  Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.

Authors:  Ge Qin; Fei Xu; Tao Qin; Qiufan Zheng; Dingbo Shi; Wen Xia; Yun Tian; Yanlai Tang; Jingshu Wang; Xiangshen Xiao; Wuguo Deng; Shusen Wang
Journal:  Oncotarget       Date:  2015-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.